A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein

Signorino G, Covaceuszach S, Bozzi M, Hübner W, Mönkemöller V, Konarev PV, Cassetta A, Brancaccio A, Sciandra F (2018)
HUMAN MUTATION 39(2): 266-280.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ;
Abstract / Bemerkung
Dystroglycan (DG) is a cell adhesion complex composed by two subunits, the highly glycosylated alpha-DG and the transmembrane alpha-DG. In skeletal muscle, DG is involved in dystroglycanopathies, a group of heterogeneous muscular dystrophies characterized by a reduced glycosylation of alpha-DG. The genes mutated in secondary dystroglycanopathies are involved in the synthesis of O-mannosyl glycans and in the O-mannosylation pathway of alpha-DG. Mutations in the DG gene (DAG1), causing primary dystroglycanopathies, destabilize the alpha-DG core protein influencing its binding to modifying enzymes. Recently, a homozygous mutation (p.Cys699Phe) hitting the -DG ectodomain has been identified in a patient affected by muscle-eye-brain disease with multicystic leucodystrophy, suggesting that other mechanisms than hypoglycosylation of alpha-DG could be implicated in dystroglycanopathies. Herein, we have characterized the DG murine mutant counterpart by transfection in cellular systems and high-resolution microscopy. We observed that the mutation alters the DG processing leading to retention of its uncleaved precursor in the endoplasmic reticulum. Accordingly, small-angle X-ray scattering data, corroborated by biochemical and biophysical experiments, revealed that the mutation provokes an alteration in the alpha-DG ectodomain overall folding, resulting in disulfide-associated oligomerization. Our data provide the first evidence of a novel intracellular mechanism, featuring an anomalous endoplasmic reticulum-retention, underlying dystroglycanopathy.
Erscheinungsjahr
Zeitschriftentitel
HUMAN MUTATION
Band
39
Ausgabe
2
Seite(n)
266-280
ISSN
eISSN
PUB-ID

Zitieren

Signorino G, Covaceuszach S, Bozzi M, et al. A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. HUMAN MUTATION. 2018;39(2):266-280.
Signorino, G., Covaceuszach, S., Bozzi, M., Hübner, W., Mönkemöller, V., Konarev, P. V., Cassetta, A., et al. (2018). A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. HUMAN MUTATION, 39(2), 266-280. doi:10.1002/humu.23370
Signorino, G., Covaceuszach, S., Bozzi, M., Hübner, W., Mönkemöller, V., Konarev, P. V., Cassetta, A., Brancaccio, A., and Sciandra, F. (2018). A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. HUMAN MUTATION 39, 266-280.
Signorino, G., et al., 2018. A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. HUMAN MUTATION, 39(2), p 266-280.
G. Signorino, et al., “A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein”, HUMAN MUTATION, vol. 39, 2018, pp. 266-280.
Signorino, G., Covaceuszach, S., Bozzi, M., Hübner, W., Mönkemöller, V., Konarev, P.V., Cassetta, A., Brancaccio, A., Sciandra, F.: A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. HUMAN MUTATION. 39, 266-280 (2018).
Signorino, Giulia, Covaceuszach, Sonia, Bozzi, Manuela, Hübner, Wolfgang, Mönkemöller, Viola, Konarev, Petr V., Cassetta, Alberto, Brancaccio, Andrea, and Sciandra, Francesca. “A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein”. HUMAN MUTATION 39.2 (2018): 266-280.

3 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A molecular overview of the primary dystroglycanopathies.
Brancaccio A., J Cell Mol Med 23(5), 2019
PMID: 30838779

65 References

Daten bereitgestellt von Europe PubMed Central.

SEA domain proteolysis determines the functional composition of dystroglycan.
Akhavan A, Crivelli SN, Singh M, Lingappa VR, Muschler JL., FASEB J. 22(2), 2007
PMID: 17905726
Biochemical characterization of MLC1 protein in astrocytes and its association with the dystrophin-glycoprotein complex.
Ambrosini E, Serafini B, Lanciotti A, Tosini F, Scialpi F, Psaila R, Raggi C, Di Girolamo F, Petrucci TC, Aloisi F., Mol. Cell. Neurosci. 37(3), 2007
PMID: 18165104
Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.
Bartoli M, Gicquel E, Barrault L, Soheili T, Malissen M, Malissen B, Vincent-Lacaze N, Perez N, Udd B, Danos O, Richard I., Hum. Mol. Genet. 17(9), 2008
PMID: 18252745
The extracellular matrix protein agrin promotes heart regeneration in mice.
Bassat E, Mutlak YE, Genzelinakh A, Shadrin IY, Baruch Umansky K, Yifa O, Kain D, Rajchman D, Leach J, Riabov Bassat D, Udi Y, Sarig R, Sagi I, Martin JF, Bursac N, Cohen S, Tzahor E., Nature 547(7662), 2017
PMID: 28581497
Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D.
Bianchini E, Fanin M, Mamchaoui K, Betto R, Sandona D., Hum. Mol. Genet. 23(14), 2014
PMID: 24565866
Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY).
Blanchet CE, Spilotros A, Schwemmer F, Graewert MA, Kikhney A, Jeffries CM, Franke D, Mark D, Zengerle R, Cipriani F, Fiedler S, Roessle M, Svergun DI., J Appl Crystallogr 48(Pt 2), 2015
PMID: 25844078
Combined spike-related functional MRI and multiple source analysis in the non-invasive spike localization of benign rolandic epilepsy.
Boor R, Jacobs J, Hinzmann A, Bauermann T, Scherg M, Boor S, Vucurevic G, Pfleiderer C, Kutschke G, Stoeter P., Clin Neurophysiol 118(4), 2007
PMID: 17317297
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan.
Boffi A, Bozzi M, Sciandra F, Woellner C, Bigotti MG, Ilari A, Brancaccio A., Biochim. Biophys. Acta 1546(1), 2001
PMID: 11257514
Functional diversity of dystroglycan.
Bozzi M, Morlacchi S, Bigotti MG, Sciandra F, Brancaccio A., Matrix Biol. 28(4), 2009
PMID: 19303439
The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.
Bozzi M, Cassetta A, Covaceuszach S, Bigotti MG, Bannister S, Hubner W, Sciandra F, Lamba D, Brancaccio A., PLoS ONE 10(5), 2015
PMID: 25932631
The N-terminal region of alpha-dystroglycan is an autonomous globular domain.
Brancaccio A, Schulthess T, Gesemann M, Engel J., Eur. J. Biochem. 246(1), 1997
PMID: 9210479
Structural basis of laminin binding to the LARGE glycans on dystroglycan.
Briggs DC, Yoshida-Moriguchi T, Zheng T, Venzke D, Anderson ME, Strazzulli A, Moracci M, Yu L, Hohenester E, Campbell KP., Nat. Chem. Biol. 12(10), 2016
PMID: 27526028
Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Carmignac V, Quere R, Durbeej M., Hum. Mol. Genet. 20(3), 2010
PMID: 21084425
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.
Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE., Cell 63(4), 1990
PMID: 1699669
The ubiquitin-proteasome system and autophagy: Coordinated and independent activities.
Cohen-Kaplan V, Livneh I, Avni N, Cohen-Rosenzweig C, Ciechanover A., Int. J. Biochem. Cell Biol. 79(), 2016
PMID: 27448843
Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
Collins I, Wang H, Caldwell JJ, Chopra R., Biochem. J. 474(7), 2017
PMID: 28298557
Laminin polymerization induces a receptor-cytoskeleton network.
Colognato H, Winkelmann DA, Yurchenco PD., J. Cell Biol. 145(3), 1999
PMID: 10225961
Structural flexibility of human α-dystroglycan.
Covaceuszach S, Bozzi M, Bigotti MG, Sciandra F, Konarev PV, Brancaccio A, Cassetta A., FEBS Open Bio 7(8), 2017
PMID: 28781947
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of α-dystroglycan.
Covaceuszach S, Bozzi M, Bigotti MG, Sciandra F, Konarev PV, Brancaccio A, Cassetta A., PLoS ONE 12(10), 2017
PMID: 29036200
The alpha-dystroglycan-beta-dystroglycan complex. Membrane organization and relationship to an agrin receptor.
Deyst KA, Bowe MA, Leszyk JD, Fallon JR., J. Biol. Chem. 270(43), 1995
PMID: 7592785
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan.
Di Stasio E, Sciandra F, Maras B, Di Tommaso F, Petrucci TC, Giardina B, Brancaccio A., Biochem. Biophys. Res. Commun. 266(1), 1999
PMID: 10581202
DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of α-dystroglycan.
Dong M, Noguchi S, Endo Y, Hayashi YK, Yoshida S, Nonaka I, Nishino I., Neurology 84(3), 2014
PMID: 25503980
NADPH oxidase activator p67(phox) behaves in solution as a multidomain protein with semi-flexible linkers.
Durand D, Vives C, Cannella D, Perez J, Pebay-Peyroula E, Vachette P, Fieschi F., J. Struct. Biol. 169(1), 2009
PMID: 19723583
The effects of post-translational processing on dystroglycan synthesis and trafficking.
Esapa CT, Bentham GR, Schroder JE, Kroger S, Blake DJ., FEBS Lett. 555(2), 2003
PMID: 14644417
Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy.
Geis T, Marquard K, Rodl T, Reihle C, Schirmer S, von Kalle T, Bornemann A, Hehr U, Blankenburg M., Neurogenetics 14(3-4), 2013
PMID: 24052401
La diffraction des rayons X aux tres petits angles: Applications a l'etude de phenomenes ultramicroscopiques
Guinier, Annales de Physique 12(), 1939
A dystroglycan mutation associated with limb-girdle muscular dystrophy.
Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltran-Valero de Bernabe D, Gundesli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MB, Accardi A, Talim B, Muntoni F, Topaloglu H, Dincer P, Campbell KP., N. Engl. J. Med. 364(10), 2011
PMID: 21388311
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP., Nature 355(6362), 1992
PMID: 1741056
Role of glycosylation in nucleating protein folding and stability.
Jayaprakash NG, Surolia A., Biochem. J. 474(14), 2017
PMID: 28673927
Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT., Neuromuscul. Disord. 13(5), 2003
PMID: 12798792
Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy.
Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, Akasaka-Manya K, Furukawa JI, Mizuno M, Kawakami H, Shinohara Y, Wada Y, Endo T, Toda T., Cell Rep 14(9), 2016
PMID: 26923585
Molecular recognition by LARGE is essential for expression of functional dystroglycan.
Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, Campbell KP., Cell 117(7), 2004
PMID: 15210115
PRIMUS: a Windows PC-based system for small-angle scattering data analysis
Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI., J Appl Crystallogr 36(), 2003
PMID: c7019
Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.
Lin YY, White RJ, Torelli S, Cirak S, Muntoni F, Stemple DL., Hum. Mol. Genet. 20(9), 2011
PMID: 21317159
Proteasome inhibitors in cancer therapy.
Manasanch EE, Orlowski RZ., Nat Rev Clin Oncol 14(7), 2017
PMID: 28117417
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP., Nature 418(6896), 2002
PMID: 12140558
Mixed disulfide formation in vitro between a glycoprotein substrate and yeast oligosaccharyltransferase subunits Ost3p and Ost6p.
Mohd Yusuf SN, Bailey UM, Tan NY, Jamaluddin MF, Schulz BL., Biochem. Biophys. Res. Commun. 432(3), 2013
PMID: 23416356
The inside and out of dystroglycan post-translational modification.
Moore CJ, Winder SJ., Neuromuscul. Disord. 22(11), 2012
PMID: 22770978
Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation.
Morikawa Y, Heallen T, Leach J, Xiao Y, Martin JF., Nature 547(7662), 2017
PMID: 28581498
Insertion of a myc-tag within α-dystroglycan domains improves its biochemical and microscopic detection.
Morlacchi S, Sciandra F, Bigotti MG, Bozzi M, Hubner W, Galtieri A, Giardina B, Brancaccio A., BMC Biochem. 13(), 2012
PMID: 22835149
α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
Palmieri V, Bozzi M, Signorino G, Papi M, De Spirito M, Brancaccio A, Maulucci G, Sciandra F., Biochim Biophys Acta Mol Basis Dis 1863(9), 2017
PMID: 28572004
New developments in the ATSAS program package for small-angle scattering data analysis
Petoukhov MV, Franke D, Shkumatov AV, Tria G, Kikhney AG, Gajda M, Gorba C, Mertens HDT, Konarev PV, Svergun DI., J Appl Crystallogr 45(), 2012
PMID: c7010
The combined use of the Thermofluor assay and ThermoQ analytical software for the determination of protein stability and buffer optimization as an aid in protein crystallization
Phillips, Current Protocols in Molecular Biology. (), 2011

Porod, 1982
Assessing protein disorder and induced folding.
Receveur-Brechot V, Bourhis JM, Uversky VN, Canard B, Longhi S., Proteins 62(1), 2006
PMID: 16287116
Absence of α- and β-dystroglycan is associated with Walker-Warburg syndrome.
Riemersma M, Mandel H, van Beusekom E, Gazzoli I, Roscioli T, Eran A, Gershoni-Baruch R, Gershoni M, Pietrokovski S, Vissers LE, Lefeber DJ, Willemsen MA, Wevers RA, van Bokhoven H., Neurology 84(21), 2015
PMID: 25934851
Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci TC., Biochem. Biophys. Res. Commun. 274(1), 2000
PMID: 10903901
Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency.
Schulz BL, Stirnimann CU, Grimshaw JP, Brozzo MS, Fritsch F, Mohorko E, Capitani G, Glockshuber R, Grutter MG, Aebi M., Proc. Natl. Acad. Sci. U.S.A. 106(27), 2009
PMID: 19549845
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan.
Sciandra F, Schneider M, Giardina B, Baumgartner S, Petrucci TC, Brancaccio A., Eur. J. Biochem. 268(16), 2001
PMID: 11502221
Dystroglycan is associated to the disulfide isomerase ERp57.
Sciandra F, Angelucci E, Altieri F, Ricci D, Hubner W, Petrucci TC, Giardina B, Brancaccio A, Bozzi M., Exp. Cell Res. 318(19), 2012
PMID: 22814252
Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates.
Singh SM, Kongari N, Cabello-Villegas J, Mallela KM., Proc. Natl. Acad. Sci. U.S.A. 107(34), 2010
PMID: 20696926
Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications.
Soheili T, Gicquel E, Poupiot J, N'Guyen L, Le Roy F, Bartoli M, Richard I., Hum. Mutat. 33(2), 2011
PMID: 22095924
Dystroglycan, a scaffold for the ERK-MAP kinase cascade.
Spence HJ, Dhillon AS, James M, Winder SJ., EMBO Rep. 5(5), 2004
PMID: 15071496
Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children.
van der Knaap MS, Barth PG, Stroink H, van Nieuwenhuizen O, Arts WF, Hoogenraad F, Valk J., Ann. Neurol. 37(3), 1995
PMID: 7695231
Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association.
Watanabe N, Sasaoka T, Noguchi S, Nishino I, Tanaka T., Genes Cells 12(1), 2007
PMID: 17212656
The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.
Willer T, Inamori K, Venzke D, Harvey C, Morgensen G, Hara Y, Beltran Valero de Bernabe D, Yu L, Wright KM, Campbell KP., Elife 3(), 2014
PMID: 25279699
Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
Yoshida-Moriguchi T, Campbell KP., Glycobiology 25(7), 2015
PMID: 25882296
Functional studies of MLC1 mutations in Chinese patients with megalencephalic leukoencephalopathy with subcortical cysts.
Xie H, Wang J, Dhaunchak AS, Shang J, Kou L, Guo M, Wu Y, Gu Q, Colman D, Wu X, Jiang Y., PLoS ONE 7(3), 2012
PMID: 22416245

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 29134705
PubMed | Europe PMC

Suchen in

Google Scholar